Under conditions of metabolic dysregulation or disease, insulin resistance of the liver promotes inappropriate upregulation of gluconeogenesis while de novo lipogenesis (DNL) pathways remain insulin sensitive, contributing to hyperglycemia and hepatic lipid accumulation, respectively (Brown and Goldstein, 2008; Figure 4). Here, INS is linked to Hyperglycemia.